Treatment of pediatric refractory or relapsed Epstein–Barr virus‐associated hemophagocytic syndrome with PD‐1 inhibitors
PD-1 inhibitors are an effective salvage therapy and can provide a bridge to allo-HSCT for pediatric patients with r/r EBV-HLH. However, side effects should be monitered.
Authors
- Kun‐yin Qiu (ORCID: https://orcid.org/0000-0002-1809-0206)
- Shu-yi Guo
- Jiaying Lei
- Jian Wang (ORCID: https://orcid.org/0000-0002-5137-0330)
- Dun‐hua Zhou (ORCID: https://orcid.org/0000-0002-8173-4924)
- Jianpei Fang
- Xiao‐Qin Wu
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen Memorial Hospital (CN)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1002/pbc.31340
- Citations
- 2
- Primary Topic
- Autoimmune and Inflammatory Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.91